These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 29974277

  • 21. Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy.
    Singh SR, Sahoo NK, Goud NR, Chhablani J.
    Indian J Ophthalmol; 2019 Jul; 67(7):1114-1118. PubMed ID: 31238423
    [Abstract] [Full Text] [Related]

  • 22. Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Kim JH, Kim JW, Kim CG, Lee DW.
    Graefes Arch Clin Exp Ophthalmol; 2020 Aug; 258(8):1677-1685. PubMed ID: 32361804
    [Abstract] [Full Text] [Related]

  • 23. Aflibercept Treatment in Polypoidal Choroidal Vasculopathy: Results of a Prospective Study in a Caucasian Population.
    Wolff B, Vasseur V, Cahuzac A, Coscas F, Castelnovo L, Favard C, Michel G, Français C, Salomon L, Mauget-Faÿsse M.
    Ophthalmologica; 2018 Aug; 240(4):208-212. PubMed ID: 29804123
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability.
    Nomura Y, Yanagi Y.
    Jpn J Ophthalmol; 2015 Jul; 59(4):261-5. PubMed ID: 25983109
    [Abstract] [Full Text] [Related]

  • 27. Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration: A Prospective Study.
    Maruko I, Ogasawara M, Yamamoto A, Itagaki K, Hasegawa T, Arakawa H, Nakayama M, Koizumi H, Okada AA, Sekiryu T, Iida T.
    Ophthalmol Retina; 2020 Aug; 4(8):767-776. PubMed ID: 32417356
    [Abstract] [Full Text] [Related]

  • 28. High-frequency aflibercept injections in persistent neovascular age-related macular degeneration.
    Muftuoglu IK, Tsai FF, Gaber R, Alam M, Meshi A, Freeman WR.
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):709-717. PubMed ID: 27878592
    [Abstract] [Full Text] [Related]

  • 29. A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration.
    Park DH, Sun HJ, Lee SJ.
    Int Ophthalmol; 2017 Oct; 37(5):1205-1214. PubMed ID: 27826933
    [Abstract] [Full Text] [Related]

  • 30. Development of Age-Related Macular Degeneration (AMD) in the Fellow Eye of Patients with AMD Treated by Treat-and-Extend Intravitreal Therapy with Aflibercept.
    Mimura K, Matsumoto H, Morimoto M, Akiyama H.
    Ophthalmologica; 2018 Oct; 239(2-3):121-127. PubMed ID: 29169154
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
    Gillies MC, Hunyor AP, Arnold JJ, Guymer RH, Wolf S, Ng P, Pecheur FL, McAllister IL.
    JAMA Ophthalmol; 2019 Apr 01; 137(4):372-379. PubMed ID: 30676617
    [Abstract] [Full Text] [Related]

  • 36. Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study.
    Kim JH, Lee TG, Chang YS, Kim CG, Cho SW.
    Br J Ophthalmol; 2016 Dec 01; 100(12):1634-1639. PubMed ID: 26951770
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
    Steinle NC, Du W, Gibson A, Saroj N.
    Ophthalmol Retina; 2021 Feb 01; 5(2):141-150. PubMed ID: 32652314
    [Abstract] [Full Text] [Related]

  • 40. Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.
    Cho HJ, Kim HS, Jang YS, Han JI, Lew YJ, Lee TG, Kim CG, Kim JW.
    Am J Ophthalmol; 2013 Dec 01; 156(6):1192-1200.e1. PubMed ID: 24011522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.